(Q43985449)

English

Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Duration of serum antibodies elicited by Haemophilus influenzae type b capsular polysaccharide alone or conjugated to tetanus toxoid in 18- to 23-month-old children (English)

1 reference

Europe PubMed Central

28 November 2017

1 reference

based on heuristic

inferred from title

tetanus vaccine

1 reference

based on heuristic

inferred from title

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

author name string

Claesson BA

1

1 reference

Europe PubMed Central

28 November 2017

Schneerson R

2

1 reference

Europe PubMed Central

28 November 2017

Trollfors B

3

1 reference

Europe PubMed Central

28 November 2017

Lagergård T

4

1 reference

Europe PubMed Central

28 November 2017

Taranger J

5

1 reference

Europe PubMed Central

28 November 2017

Robbins JB

6

1 reference

Europe PubMed Central

28 November 2017

language of work or name

0 references

publication date

1 June 1990

1 reference

Europe PubMed Central

28 November 2017

The Journal of Pediatrics

1 reference

Europe PubMed Central

28 November 2017

116

1 reference

Europe PubMed Central

28 November 2017

6

1 reference

Europe PubMed Central

28 November 2017

929-931

1 reference

Europe PubMed Central

28 November 2017

Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980655-9

7 January 2021

Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980655-9

7 January 2021

Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980655-9

7 January 2021

Persistence of antibody and response to booster dose of Haemophilus influenzae type b polysaccharide diphtheria toxoid conjugate vaccine in infants immunized at 9 to 15 months of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980655-9

7 January 2021

Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980655-9

7 January 2021

Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980655-9

7 January 2021

Comparison between radioimmunoassay and direct and indirect enzyme-linked immunosorbent assays for determination of antibodies against Haemophilus influenzae type b capsular polysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980655-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0022-3476(05)80655-9

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43985449&oldid=2105314027"